Cellshield Limited 1818559 true 2024-01-01 2024-12-31 2024-12-31 The principal activity of the company is the supply of safety equipment. Digita Accounts Production Advanced 6.30.9574.0 true S K Hodgkiss CBE DL P M Norris FCCA true true 1818559 2024-01-01 2024-12-31 1818559 2024-12-31 1818559 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2024-12-31 1818559 core:ShareCapital 2024-12-31 1818559 core:CurrentFinancialInstruments 2024-12-31 1818559 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 1818559 bus:FRS102 2024-01-01 2024-12-31 1818559 bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 1818559 bus:FullAccounts 2024-01-01 2024-12-31 1818559 bus:RegisteredOffice 2024-01-01 2024-12-31 1818559 bus:Director1 2024-01-01 2024-12-31 1818559 bus:Director2 2024-01-01 2024-12-31 1818559 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2024-01-01 2024-12-31 1818559 bus:EntityNoLongerTradingButTradedInPast 2024-01-01 2024-12-31 1818559 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 1818559 1 2024-01-01 2024-12-31 1818559 countries:England 2024-01-01 2024-12-31 1818559 2023-01-01 2023-12-31 1818559 2023-12-31 1818559 bus:OrdinaryShareClass1 bus:Non-cumulativeShares 2023-12-31 1818559 core:ShareCapital 2023-12-31 1818559 core:CurrentFinancialInstruments 2023-12-31 1818559 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 1818559



Cellshield Limited
Annual Report and
Unaudited Financial Statements

31 December 2024

 

Cellshield Limited

Statement of Financial Position
31 December 2024

Note

2024
£

2023
£

Current assets

 

Debtors

3

200

200

Capital and reserves

 

Called up share capital

4

200

200

Shareholders' funds

 

200

200

For the financial year ending 31 December 2024 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Directors' responsibilities:

The members have not required the Company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The Directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

Approved and authorised by the Board on 12 May 2025 and signed on its behalf by:
 

.........................................
P M Norris FCCA
Director

Company Registration Number: 1818559

 

Cellshield Limited

Notes to the Unaudited Financial Statements
31 December 2024

1

General information

The Company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Brandlesholme House
Brandlesholme Road
Bury
Lancashire
BL8 1JJ

These financial statements were authorised for issue by the Board on 12 May 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with applicable United Kingdom accounting standards, including Financial Reporting Standard 102 – 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' ('FRS 102'), and with the Companies Act 2006.

Basis of preparation

The financial statements have been prepared under the historical cost convention.

As noted in the Directors report, the directors consider that the going concern basis of accounting is appropriate. In making this decision the directors have considered the impact of the Covid 19 pandemic on the company.

The financial statements are prepared in sterling which is the functional currency of the company.

Departure from requirements of FRS 102

The company is a wholly owned subsidiary of William Hare Group Limited, the consolidated accounts of which are publicly available. Accordingly, the company has taken advantage of the exemption in FRS 102 from disclosing transactions with members or investees of the William Hare Group Limited group.

Going concern

The financial statements have been prepared on a going concern basis.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Cellshield Limited

Notes to the Unaudited Financial Statements
31 December 2024

3

Debtors

Current

Note

2024
£

2023
£

Amounts owed by related parties

200

200

   

200

200

4

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary share of £1 each

200

200

200

200

       

5

Parent and ultimate parent undertaking

The Company's immediate parent is William Hare Group Limited, incorporated in England.

 The ultimate controlling party is the majority of the directors of the ultimate holding company.

6

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 2 (2023 - 2).